论文信息 - Aerosolised prostacyclin in adult respiratory distress syndrome - 字舞流文

Aerosolised prostacyclin in adult respiratory distress syndrome

W. Seeger | F. Grimminger | J. Pilch | D. Walmrath | T. Schneider | Werner Seeger | Thomas Schneider

[1] R. Rossaint,et al. Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, The New England journal of medicine.

[2] E. Shaffer,et al. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[3] T. Higenbottam,et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension , 1991, The Lancet.

[4] J. Wain,et al. Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator Reversing Hypoxic Pulmonary Vasoconstriction , 1991, Circulation.

[5] C. Mélot,et al. Prostaglandin E1 in the adult respiratory distress syndrome. Benefit for pulmonary hypertension and cost for pulmonary gas exchange. , 1989, The American review of respiratory disease.

[6] S. Holgate,et al. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. , 1988, Journal of applied physiology.

[7] J Tinker,et al. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. , 1987, The New England journal of medicine.

[8] T. Higenbottam. The place of prostacyclin in the clinical management of primary pulmonary hypertension. , 1987, The American review of respiratory disease.

[9] J B West,et al. Measurement of continuous distributions of ventilation-perfusion ratios: theory. , 1974, Journal of applied physiology.